Edwin Wagena

Edwin Wagena is the Chief Executive Officer at Sutura Therapeutics Ltd and also holds the title of Chief Operating Officer and Advisor. Edwin is involved in the integrated development of innovative therapies and technology platforms at TIC-T. Previously, Edwin served as the Chief Executive Officer at Atelerix Ltd, Chief Operating Officer at Rexgenero, Chief Development Officer at Kiadis Pharma, and held various scientific roles at Maastricht University and University Nijmegen. Edwin holds a Ph.D. from Maastricht University and a Master's Degree in Health Sciences from the University of Groningen.